It has been widely documented that vessel co-option is a VEGF-independent mechanism of tumor vascularization, mainly driven by the proangiogenic factor ANG-2 without an increase in VEGF expression, and activation of matrix metalloproteinase-2 (MMP-2), which promotes glioma cell invasion [36]. Here, VEGFA is linked to central nervous system cancer.